Curis
CRIS
#10277
Rank
โ‚น2.24 B
Marketcap
โ‚น56.19
Share price
-1.33%
Change (1 day)
-73.20%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): -โ‚น315.89

According to Curis's latest financial reports the company's current EPS (TTM) is -โ‚น348.32. In 2024 the company made an earnings per share (EPS) of -โ‚น667.22 an increase over its 2023 EPS that were of -โ‚น857.04.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น315.89-52.66%
2024-โ‚น667.22-22.15%
2023-โ‚น857.04-26.17%
2022-โ‚น1,16122.3%
2021-โ‚น949.10-25.37%
2020-โ‚น1,272-30.93%
2019-โ‚น1,841-2.02%
2018-โ‚น1,879
2016-โ‚น4,271-10%
2015-โ‚น4,746138.1%
2014-โ‚น1,99340%
2013-โ‚น1,424-25%
2012-โ‚น1,89866.67%
2011-โ‚น1,139

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น129.08-137.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น328.39-194.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น34.17-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚น274.29-178.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น369.20 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚น1,067 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น133.82-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA